An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization

References

• Agarwal P, Rupenthal ID. 2013. Injectable implants for the sustained release of protein and peptide drugs. Drug Discov Today. 18(7–8):337–349.
   PubMed Web of Science ®Google Scholar
• Agossa K, Delepierre A, Lizambard M, Delcourt-Debruyne E, Siepmann J, Siepmann F, Neut C. 2020. In-situ forming implants for dual controlled release of chlorhexidine and ibuprofen for periodontitis treatment: microbiological and mechanical key properties. J Drug Deliv Sci Technol. 60:101956.
   Web of Science ®Google Scholar
• Ahmed TA, Alharby YA, El-Helw AM, Hosny KM, El-Say KM. 2016. Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation. Drug Des Devel Ther. 10:405–415.
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Hussain Z. 2010. Preparation of parenteral in situ gel formulation based on smart PLGA polymer: concepts to decrease initial drug burst and extend drug release. In: Rohman G, editor. Biodegradable polymers: recent developments and new perspectives. Croatia: IAPC Publishing. Chapter 9; p. 315–336.
   Google Scholar
• Ahmed TA, Ibrahim HM, Samy AM, Kaseem A, Nutan MTH, Hussain MD. 2014. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability. AAPS PharmSciTech. 15(3):772–780.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Alabdollah F, Sadeghi F, Mohammadi M, Abnous K, Ramezani M, Hadizadeh F. 2016. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: in vitro and in vivo evaluation. J Control Release. 227:58–70.
   PubMed Web of Science ®Google Scholar
• Al-Jawadi S, Capasso P, Sharma M. 2018. The road to market implantable drug delivery systems: a review on US FDA’s regulatory framework and quality control requirements. Pharm Dev Technol. 23(10):953–963.
   PubMed Web of Science ®Google Scholar
• Allahyari M, Mohit E. 2016. Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother. 12(3):806–828.
   PubMed Web of Science ®Google Scholar
• Amini-Fazl MS. 2021. Biodegradation study of PLGA as an injectable in situ depot-forming implant for controlled release of paclitaxel. Polym Bull. 1–14.
   Web of Science ®Google Scholar
• Ashjari M, Khoee S, Mahdavian AR, Rahmatolahzadeh R. 2012. Self-assembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values. J Mater Sci Mater Med. 23(4):943–953.
   PubMed Web of Science ®Google Scholar
• Astaneh R, Erfan M, Moghimi H, Mobedi H. 2009. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior. J Pharm Sci. 98(1):135–145.
   PubMed Web of Science ®Google Scholar
• Augusthy AR, Chandran S, Vipin KV. 2017. Design and evaluation of an in situ forming implant system of an anti-inflammatory drug. Indo Am J Pharm Res. 4(4):983–994.
   Google Scholar
• Avgoustakis K. 2008. Polylactic-co-glycolic acid (PLGA). In: Wnek GE, Bowlin GL, editors. Encyclopedia of biomaterials and biomedical engineering. 2nd ed. New York (NY): Informa HealthCare; p. 2259–2269.
   Google Scholar
• Bakhshi R, Vasheghani-Farahani E, Mobedi H, Jamshidi A, Khakpour M. 2006. The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant. Polym Adv Technol. 17(5):354–359.
   Web of Science ®Google Scholar
• Barakat SS, Nasr M, Ahmed RF, Badawy SS, Mansour S. 2017. Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model. Sci Rep. 7(1):9910.
   PubMedGoogle Scholar
• Behrens AM, Kim J, Hotaling N, Seppala JE, Kofinas P, Tutak W. 2016. Rapid fabrication of poly(DL-lactide) nanofiber scaffolds with tunable degradation for tissue engineering applications by air-brushing. Biomed Mater. 1(3):1–17.
   Google Scholar
• Bisht R, Jaiswal JK, Chen Y, Jin J, Rupenthal ID. 2016. Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye. Expert Opin Drug Deliv. 13(7):953–962.
   PubMed Web of Science ®Google Scholar
• Bisht R, Jaiswal JK, Oliver VF, Eurtivong C, Reynisson J, Rupenthal ID. 2017. Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery. J Drug Deliv Sci Technol. 40:142–156.
   Web of Science ®Google Scholar
• Bittner B, Richter W, Schmidt J. 2018. Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities. BioDrugs. 32(5):425–440.
   PubMed Web of Science ®Google Scholar
• Bode C, Kranz H, Siepmann F, Siepmann J. 2018. In-situ forming PLGA implants for intraocular dexamethasone delivery. Int J Pharm. 548(1):337–348.
   PubMedGoogle Scholar
• Borgheti-Cardoso LN, Kooijmans SAA, Fens MHAM, Van der Meel R, Vicentini FTMC, Fantini MCA, Bentley MVLB, Schiffelers RM. 2017. In situ gelling liquid crystalline system as local siRNA delivery system. Mol Pharm. 14(5):1681–1690.
   PubMedGoogle Scholar
• Browne DC, Kieselmann K. 2010. Low-level drug release-rate testing of ocular implants using USP Apparatus 4 dissolution and HPLC end analysis. Dissolution Technol. 17(1):12–14.
   Web of Science ®Google Scholar
• Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. 2002. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm Res. 19(11):1761–1768.
   PubMedGoogle Scholar
• Cabane E, Zhang X, Langowska K, Palivan CG, Meier W. 2012. Stimuli-responsive polymers and their applications in nanomedicine. Biointerphases. 7(1-4):9.
   PubMed Web of Science ®Google Scholar
• Camargo JA, Sapin A, Nouvel C, Daloz D, Leonard M, Bonneaux F, Six JL, Maincent P. 2013. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. Drug Dev Ind Pharm. 39(1):146–155.
   PubMed Web of Science ®Google Scholar
• Chaudhary B, Verma S. 2014. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections. Sci World J. 2014:1–7.
   Web of Science ®Google Scholar
• Che X, Wang L, Li Q, Liu H. 2014. Injectable long-term control-released in-situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in-vitro and in-vivo evaluation. Int J Pharm. 469(1):23–30.
   PubMedGoogle Scholar
• Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. 2001. Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym. 46(1):39–47.
   Web of Science ®Google Scholar
• Chhabra S, Sachdeva V, Singh S. 2007. Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer based in situ gel forming controlled release drug delivery system. Int J Pharm. 342(1–2):72–77.
   PubMedGoogle Scholar
• D’Souza SS, DeLuca PP. 2006. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res. 23(3):460–474.
   PubMed Web of Science ®Google Scholar
• Dhir S, Saffi KA, Kamalpuria N, Mishra D. 2016. An overview of in situ gelling system. Int J Pharm Life Sci. 7(8):5135–5156.
   Google Scholar
• Dong S, Wang S, Zheng C, Liang W, Huang Y. 2011. An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics. Soft Matter. 7(12):5873–5878.
   Web of Science ®Google Scholar
• Dong WY, Körber M, López Esguerra V, Bodmeier R. 2006. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. J Control Release. 115(2):158–167.
   PubMed Web of Science ®Google Scholar
• Dunn RL, English JP, Cowsar DR, Vanderbilt DP, inventors; Southern Research Institute, assignee. 1990. Jul 03. Biodegradable in situ forming implants and methods of producing the same. United States patent US 4,938,763.
   Google Scholar
• Dunn RL, English JP, Cowsar DR, Vanderbilt DP, inventors; Atrix Laboratories Inc, assignee. 1994. Jan 11. Biodegradable in situ forming implants and methods of producing the same. United States patent US 5,278,201.
   Google Scholar
• Dutta K, Das R, Ling J, Monibas RM, Carballo-Jane E, Kekec A, Feng DD, Lin S, Mu J, Saklatvala R, et al. 2020. In situ forming injectable thermoresponsive hydrogels for controlled delivery of biomacromolecules. ACS Omega. 5(28):17531–17542.
   PubMed Web of Science ®Google Scholar
• El-Hefian EA, Yahaya AH. 2010. Rheological study of chitosan and its blends: an overview. Maejo Int J Sci Technol. 4(02):210–220.
   Google Scholar
• Eliaz R, Szoka F. 2002. Robust and prolonged gene expression from injectable polymeric implants. Gene Ther. 9(18):1230–1237.
   PubMed Web of Science ®Google Scholar
• Elmotasem H, Awad GE. 2020. A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery. Asian J Pharm Sci. 15(5):617–636.
   PubMed Web of Science ®Google Scholar
• Elsawy MA, Kim KH, Park JW, Deep A. 2017. Hydrolytic degradation of polylactic acid (PLA) and its composites. Renew Sustain Energy Rev. 79:1346–1352.
   Web of Science ®Google Scholar
• Enayati M, Mobedi H, Hojjati-Emami S, Mirzadeh H, Jafari-Nodoushan M. 2017. In situ forming PLGA implant for 90 days controlled release of leuprolide acetate for treatment of prostate cancer. Polym Adv Technol. 28(7):867–875.
   Web of Science ®Google Scholar
• Erbetta CDC, Alves RJ, Resende JM, Freitas RFDS, Sousa RGD. 2012. Synthesis and characterization of poly(d,l-lactide co-glycolide) copolymer. J Biomater Nanobiotechnol. 3(2):208–225.
   Google Scholar
• Farhangi M, Dadashzadeh S, Bolourchian N. 2017. Biodegradable gelatin microspheres as controlled release intraarticular delivery system: the effect of formulation variables. Indian J Pharm Sci. 79(1):105–112.
   Web of Science ®Google Scholar
• [FDA] Food and Drug Administration . 2003. United States: Food and Drug Administration. [accessed 2021 May 28]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21346_RisperdalTOC.cfm
   Google Scholar
• [FDA] Food and Drug Administration . 2016. United States: Food and Drug Administration. [accessed 2021 May 28]. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/postmarket-requirements-and-commitments
   Google Scholar
• [FDA] Food and Drug Administration . 2018a. United States: Food and Drug Administration. [accessed 2021 May 28]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210655Orig1s000TOC.cfm
   Google Scholar
• [FDA] Food and Drug Administration . 2018b. United States: Food and Drug Administration. [accessed 2021 May 28]. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/surveillance
   Google Scholar
• Forouzandeh F, Zhu X, Ahamed NN, Walton JP, Frisina RD, Borkholder DA. 2019. Modular microreservoir for active implantable drug delivery. BioRxiv. 1–18.
   Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, Axelsson A. 2011. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – a review. Int J Pharm. 415(1–2):34–52.
   PubMed Web of Science ®Google Scholar
• Gad HA. 2016. Simvastatin in-situ forming implants: preparation and characterization. Int J Pharm Pharm Sci. 7(4):44–57.
   PubMedGoogle Scholar
• Gentile P, Chiono V, Carmagnola I, Hatton PV. 2014. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci. 15(3):3640–3659.
   PubMed Web of Science ®Google Scholar
• Gu P, Wusiman A, Zhang Y, Liu Z, Bo R, Hu Y, Liu J, Wang D. 2019. Rational design of PLGA nanoparticle vaccine delivery systems to improve immune responses. Mol Pharm. 16(12):5000–5012.
   PubMedGoogle Scholar
• Gulati N, Gupta H. 2011. Parenteral drug delivery: a review. Recent Pat Drug Deliv Formul. 5(2):133–145.
   PubMedGoogle Scholar
• Güven UM, Berkman MS, Şenel B, Yazan Y. 2019. Development and in vitro/in vivo evaluation of thermo-sensitive in situ gelling systems for ocular allergy. Braz J Pharm Sci. 55:e17511.
   Web of Science ®Google Scholar
• Gyulai G, Penzes CB, Mohai M, Lohner T, Petrik P, Kurunczi S, Kiss E. 2011. Interfacial properties of hydrophilized poly(lactic-co-glycolic acid) layers with various thicknesses. J Colloid Interface Sci. 362(2):600–606.
   PubMed Web of Science ®Google Scholar
• Hadar J, Skidmore S, Garner J, Park H, Park K, Wang Y, Qin B, Jiang X. 2019. Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations. J Control Release. 304:75–89.
   PubMed Web of Science ®Google Scholar
• Haggag Y, Abdel-Wahab Y, Ojo O, Osman M, El-Gizawy S, El-Tanani M, Faheem A, McCarron P. 2016. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. Int J Pharm. 499(1–2):236–246.
   PubMedGoogle Scholar
• Haggag Y, Elshikh M, El-Tanani M, Bannat IM, McCarron P, Tambuwala MM. 2020. Nanoencapsulation of sophorolipids in PEGylated poly(lactide-co-glycolide) as a novel approach to target colon carcinoma in the murine model. Drug Deliv Transl Res. 10(5):1353–1366.
   PubMed Web of Science ®Google Scholar
• Haggag YA, Faheem AM, Tambuwala MM, Osman MA, El-Gizawy SA, O’Hagan B, Irwin N, McCarron PA. 2018. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure. Pharm Dev Technol. 23(4):370–381.
   PubMed Web of Science ®Google Scholar
• Haggag YA, Ibrahim RR, Hafiz AA. 2020. Design, formulation and in vivo evaluation of novel honokiol-loaded PEGylated PLGA nanocapsules for treatment of breast cancer. Int J Nanomedicine. 15:1625–1642.
   PubMed Web of Science ®Google Scholar
• Haider M, Elsayed I, Ahmed IS, Fares AR. 2021. In situ-forming microparticles for controlled release of rivastigmine: in vitro optimization and in vivo evaluation. Pharmaceuticals. 14(1):66.
   Web of Science ®Google Scholar
• Hajavi J, Ebrahimian M, Sankian M, Khakzad MR, Hashemi M. 2018. Optimization of PLGA formulation containing protein or peptide-based antigen: recent advances. J Biomed Mater Res A. 106(9):2540–2551.
   PubMed Web of Science ®Google Scholar
• Hatefi A, Amsden B. 2002. Biodegradable injectable in situ forming drug delivery systems. J Control Release. 80(1–3):9–28.
   PubMed Web of Science ®Google Scholar
• Hines DJ, Kaplan DL. 2013. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights . Crit Rev Ther Drug Carrier Syst. 30(3):257–276.
   PubMed Web of Science ®Google Scholar
• Homayun B, Lin X, Choi H. 2019. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 11(3):129.
   PubMed Web of Science ®Google Scholar
• Hosny KM, Rizg WY. 2018. Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis. PLoS One. 13(6):e0197540.
   PubMed Web of Science ®Google Scholar
• Hosny KM, Rizg WY, Khallaf RA. 2020. Preparation and optimization of in situ gel loaded with rosuvastatin-ellagic acid nanotransfersomes to enhance the anti-proliferative activity. Pharmaceutics. 12(3):263.
   Web of Science ®Google Scholar
• Hua Y, Wang Z, Wang D, Lin X, Liu B, Zhang H, Gao J, Zheng A. 2021. Key factor study for generic long-acting PLGA microspheres based on a reverse engineering of Vivitrol®. Molecules. 26(5):1247.
   PubMed Web of Science ®Google Scholar
• Huh KM, Cho YW, Park K. 2003. PLGA-PEG block copolymers for drug formulations. Drug Deliv Technol. 3(5):44–49.
   Google Scholar
• Ibrahim HM, Ahmed TA, Hussain MD, Rahman Z, Samy AM, Kaseem AA, Nutan MT. 2014. Development of meloxicam in situ implant formulation by quality by design principle. Drug Dev Ind Pharm. 40(1):66–73.
   PubMed Web of Science ®Google Scholar
• Ibrahim TM, Eissa RG, El-Megrab NA, El-Nahas HM. 2021. Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats. J Drug Deliv Sci Technol. 61:102195.
   Web of Science ®Google Scholar
• Ibrahim TM, El-Megrab NA, El-Nahas HM. 2020. Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design. J Drug Deliv Sci Technol. 58:101803.
   Web of Science ®Google Scholar
• Inkinen S, Hakkarainen M, Albertsson AC, Södergård A. 2011. From lactic acid to poly(lactic acid) (PLA): characterization and analysis of PLA and its precursors. Biomacromolecules. 12(3):523–532.
   PubMed Web of Science ®Google Scholar
• Islam S. 2011. Lipophilic and hydrophilic drug loaded PLA/PLGA in situ implants: Studies on thermal behavior of drug & polymer and observation of parameters influencing drug burst release with corresponding effects on loading efficiency & morphology of implants. Int J Pharm Pharm Sci. 3(3):181–188.
   Google Scholar
• Jain RA, Rhodes CT, Railkar AM, Malick AW, Shah NH. 2000. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm. 50(2):257–262.
   PubMed Web of Science ®Google Scholar
• James HP, John R, Alex A, Anoop KR. 2014. Smart polymers for the controlled delivery of drugs – a concise overview. Acta Pharm Sin B. 4(2):120–127.
   PubMed Web of Science ®Google Scholar
• Jeong B, Bae YH, Kim SW. 2000. In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof. J Biomed Mater Res. 50(2):171–177.
   PubMed Web of Science ®Google Scholar
• Jerbić IŠ. 2018. Biodegradable synthetic polymers and their application in advanced drug delivery systems (DDS). Nano Tech Appl. 1(1):1–9.
   Google Scholar
• Jervis LP. 2017. A summary of recent advances in ocular inserts and implants. J Bioequivalence Bioavailab. 9(1):320–323.
   Google Scholar
• Jhaveri AM, Torchilin VP. 2014. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 5:77.
   PubMed Web of Science ®Google Scholar
• Jivawala R, Goyani M. 2017. A novel approach to deliver therapeutic agents using in situ forming implant based on solvent induced phase separation technique for long term controlled release. Int J Adv Res Rev. 2(12):50–62.
   Google Scholar
• Joshi R, Robinson DH, Himmelstein KJ. 1999. In vitro properties of an in situ forming gel for the parenteral delivery of macromolecular drugs. Pharm Dev Technol. 4(4):515–522.
   PubMed Web of Science ®Google Scholar
• Kamali H, Khodaverdi E, Hadizadeh F, Mohajeri SA, Nazari A, Jafarian AH. 2019. Comparison of in-situ forming composite using PLGA-PEG-PLGA with in-situ forming implant using PLGA: in-vitro, ex-vivo, and in-vivo evaluation of naltrexone release. J Drug Deliv Sci Technol. 50:188–200.
   Web of Science ®Google Scholar
• Kamali H, Khodaverdi E, Kaffash E, Saffari AS, Shiadeh SN, Nokhodchi A, Hadizadeh F. 2020. Optimization and in vitro evaluation of injectable sustained-release of levothyroxine using PLGA-PEG-PLGA. J Pharm Innov. 1–11.
   Web of Science ®Google Scholar
• Kamaly N, Yameen B, Wu J, Farokhzad OC. 2016. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 116(4):2602–2663.
   PubMed Web of Science ®Google Scholar
• Kane JM, Kishimoto T, Correll CU. 2013. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 12(3):216–226.
   PubMed Web of Science ®Google Scholar
• Kanwar N, Sinha VR. 2019. In situ forming depot as sustained-release drug delivery systems. Crit Rev Ther Drug Carrier Syst. 36(2):93–136.
   PubMed Web of Science ®Google Scholar
• Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. 2015. PLGA: a unique polymer for drug delivery. Ther Deliv. 6(1):41–58.
   PubMed Web of Science ®Google Scholar
• Kapoor DN, Katare OP, Dhawan S. 2012. In situ forming implant for controlled delivery of an anti-HIV fusion inhibitor. Int J Pharm. 426(1–2):132–143.
   PubMedGoogle Scholar
• Karp F, Turino LN, Helbling IM, Islan GA, Luna JA, Estenoz DA. 2021. In situ formed implants, based on PLGA and Eudragit blends, for novel florfenicol controlled release formulations. J Pharm Sci. 110(3):1270–1278.
   PubMed Web of Science ®Google Scholar
• Kempe S, Mäder K. 2012. In situ forming implants – an attractive formulation principle for parenteral depot formulations. J Control Release. 161(2):668–679.
   PubMed Web of Science ®Google Scholar
• Khodaverdi E, Delroba K, Mohammadpour F, Khameneh B, Tabassi SAS, Tafaghodi M, Kamali H, Hadizadeh F. 2020. In-vitro release evaluation of growth hormone from an injectable in-situ forming gel using PCL-PEG-PCL thermosensitive triblock. Curr Drug Deliv. 17(2):174–183.
   PubMed Web of Science ®Google Scholar
• Kondiah P, Choonara Y, Kondiah P, Marimuthu T, Kumar P, Du Toit LC, Pillay V. 2016. A review of injectable polymeric hydrogel systems for application in bone tissue engineering. Molecules. 21(11):1580.
   Web of Science ®Google Scholar
• Kumar D, Jain N, Gulati N, Nagaich U. 2013. Nanoparticles laden in situ gelling system for ocular drug targeting. J Adv Pharm Technol Res. 4(1):9–17.
   PubMedGoogle Scholar
• Lambert WJ, Peck KD. 1995. Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins. J Control Release. 33(1):189–195.
   Web of Science ®Google Scholar
• Lanao RPF, Jonker AM, Wolke JGC, Jansen JA, Hest JCM, Leeuwenburgh SCG. 2013. Physicochemical properties and applications of poly(lactic-co-glycolic acid) for use in bone regeneration. Tissue Eng Part B Rev. 19(4):380–390.
   PubMed Web of Science ®Google Scholar
• Larsen C, Larsen SW, Jensen H, Yaghmur A, Østergaard J. 2009. Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opin Drug Deliv. 6(12):1283–1295.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Shim Y, Oh J, Jeong Y, Park I, Lee HC. 2015. Folic-acid-conjugated pullulan/poly(dl-lactide-co-glycolide) graft copolymer nanoparticles for folate-receptor-mediated drug delivery. Nanoscale Res Lett. 10(1):43.
   PubMedGoogle Scholar
• Liu Q, Zhang H, Zhou G, Xie S, Zou H, Yu Y, Li G, Sun D, Zhang G, Lu Y, et al. 2010. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-coglycolide) implants. Int J Pharm. 397(1–2):122–129.
   Google Scholar
• Lin X, Yang S, Gou J, Zhao M, Zhang Y, Qi N, He H, Cai C, Tang X, Guo P. 2012. A novel risperidone-loaded SAIB–P LGA mixture matrix depot with a reduced burst release: effects of solvents and P LGA on drug release behaviors in vitro/in vivo. J Mater Sci Mater Med. 23(2):443–455.
   Google Scholar
• Liu H, Venkatraman SS. 2012a. Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems. J Pharm Sci. 101(5):1783–1793.
   PubMed Web of Science ®Google Scholar
• Liu H, Venkatraman SS. 2012b. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems. J Biomater Sci Polym Ed. 23(1-4):251–266.
   PubMed Web of Science ®Google Scholar
• Madan M, Bajaj A, Lewis S, Udupa N, Baig JA. 2009. In situ forming polymeric drug delivery systems. Indian J Pharm Sci. 71(3):242–251.
   PubMed Web of Science ®Google Scholar
• Madhav NV, Shakya AK, Shakya P, Singh K. 2009. Orotransmucosal drug delivery systems: a review. J Control Release. 140(1):2–11.
   PubMed Web of Science ®Google Scholar
• Maeda T, Kitagawa M, Hotta A, Koizumi S. 2019. Thermo-responsive nanocomposite hydrogels based on PEG-b-PLGA diblock copolymer and laponite. Polymers. 11(2):250.
   Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3(3):1377–1397.
   PubMed Web of Science ®Google Scholar
• Mallardé D, Boutignon F, Moine F, Barré E, David S, Touchet H, Ferruti P, Deghenghi R. 2003. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on Teverelix in vitro release. Int J Pharm. 261(1–2):69–80.
   PubMedGoogle Scholar
• Martins C, Sousa F, Araújo F, Sarmento B. 2018. Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications. Adv Healthc Mater. 7(1):1–24.
   Web of Science ®Google Scholar
• McCullough A. 2014. A review of testosterone pellets in the treatment of hypogonadism. Curr Sex Health Rep. 6(4):265–269.
   PubMedGoogle Scholar
• Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, et al. 2007. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology . 190(2):201–211.
   PubMed Web of Science ®Google Scholar
• Milacic V, Schwendeman SP. 2014. Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends. Pharm Res. 31(2):436–448.
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Kumar MNVR. 2007. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 119(1):77–85.
   PubMed Web of Science ®Google Scholar
• Musmade N, Jadhav A, Moin P, Patil S, Gupta A. 2019. An overview of in situ gel forming implants: Current approach towards alternative drug delivery system. JBCC. 5(1):14–21.
   Google Scholar
• Neubert A, Sternberg K, Nagel S, Harder C, Schmitz KP, Kroemer HK, Weitschies W. 2008. Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. J Control Release. 130(1):2–8.
   PubMed Web of Science ®Google Scholar
• Nikam KR, Pawar MG, Jadhav SP, Bairagi VB. 2013. Novel trends in parenteral drug delivery system: Review. Int J Pharm Technol. 5(2):2549–2577.
   Google Scholar
• Niu X, Wang L, Chen P, Li X, Zhou G, Feng Q, Fan Y. 2013. Emulsion self-assembly synthesis of chitosan/poly(lactic-co-glycolic acid) stimuli-responsive amphiphiles. Macromol Chem Phys. 214(6):700–706.
   Web of Science ®Google Scholar
• Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, Wang J, Krause RWM, Adler S, Lammers T, et al. 2020. Clinically established biodegradable long acting injectables: an industry perspective. Adv Drug Deliv Rev. 167:19–46.
   PubMed Web of Science ®Google Scholar
• Okur NU, Yozgatli V, Senyigit Z. 2020. Formulation and detailed characterization of voriconazole loaded in situ gels for ocular application. J Fac Pharm Ankara. 44(1):33–49.
   Google Scholar
• Olivier J. 2005. Drug transport to brain with targeted nanoparticles. NeuroRx. 2(1):108–119.
   PubMedGoogle Scholar
• Osorno LL, Maldonado DE, Whitener RJ, Brandley AN, Yiantsos A, Medina JD, Byrne ME. 2020. Amphiphilic PLGA-PEG-PLGA triblock copolymer nanogels varying in gelation temperature and modulus for the extended and controlled release of hyaluronic acid. J Appl Polym Sci. 137(25):48678.
   Web of Science ®Google Scholar
• Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. 2013. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release. 172(1):292–304.
   PubMed Web of Science ®Google Scholar
• Patel A, Ansari T, Vimal P, Goyani M, Deshmukh A, Akbari B. 2015. A review on PLGA based solvent induced in-situ forming implant. Inventi Rapid. 2015(4):1–14.
   Google Scholar
• Patel RB, Solorio L, Wu H, Krupka T, Exner AA. 2010. Effect of injection site on in situ implant formation and drug release in vivo. J Control Release. 147(3):350–358.
   PubMed Web of Science ®Google Scholar
• Patki M, Palekar S, Reznik S, Patel K. 2021. Self-injectable extended release formulation of remdesivir (SelfExRem): a potential formulation alternative for COVID-19 treatment. Int J Pharm. 597:120329.
   PubMedGoogle Scholar
• Patlolla VGR, Holbrook WP, Gizurarson S, Kristmundsdottir T. 2019. Doxycycline and monocaprin in situ hydrogel: Effect on stability, mucoadhesion and texture analysis and in vitro release. Gels. 5(4):47.
   Web of Science ®Google Scholar
• Phaechamud T, Mahadlek J, Charoenteeraboon J, Choopun S. 2012. Characterization and antimicrobial activity of N-methyl-2-pyrrolidone-loaded ethylene oxide-propylene oxide block copolymer thermosensitive gel. Indian J Pharm Sci. 74(6):498–504.
   PubMed Web of Science ®Google Scholar
• Pineda-Hernández MT, Pérez-Urizar JT, Ganem-Rondero A. 2020. Thermo-reversible in situ forming implant with nanostructured lipid carriers (NLC) as a delivery system for the administration of estradiol valerate. Drug Deliv Transl Res. 10(5):1393–1402.
   PubMed Web of Science ®Google Scholar
• Pitorre M, Gondé H, Haury C, Messous M, Poilane J, Boudaud D, Kanber E, Ndombina GAR, Benoit J, Bastiat G. 2017. Recent advances in nanocarrier-loaded gels: which drug delivery technologies against which diseases? J Control Release. 266:140–155.
   PubMed Web of Science ®Google Scholar
• Prabhu S, Tran LP, Betageri GV. 2005. Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants. Drug Deliv. 12(6):393–398.
   PubMed Web of Science ®Google Scholar
• Qi F, Wu J, Li H, Ma G. 2019. Recent research and development of PLGA/PLA microspheres/nanoparticles: a review in scientific and industrial aspects. Front Chem Sci Eng. 13(1):14–27.
   Web of Science ®Google Scholar
• Reddy P, Acharya SR, Acharya NS. 2015. Optimization of size controlled poly (lactide-co-glycolic acid) nanoparticles using quality by design concept. Asian J Pharm. 9(3):152–161.
   Web of Science ®Google Scholar
• Rousselle SD, Ramot Y, Nyska A, Jackson ND. 2019. Pathology of bioabsorbable implants in preclinical studies. Toxicol Pathol. 47(3):358–378.
   PubMed Web of Science ®Google Scholar
• Sabale V, Vora S. 2012. Formulation and evaluation of microemulsion-based hydrogel for topical delivery. Int J Pharm Investig. 2(3):140–149.
   PubMedGoogle Scholar
• Santamaria CM, Woodruff A, Yang R, Kohane DS. 2017. Drug delivery systems for prolonged duration local anesthesia. Mater Today . 20(1):22–31.
   Web of Science ®Google Scholar
• Schwendeman SP, Shah RB, Bailey BA, Schwendeman AS. 2014. Injectable controlled release depots for large molecules. J Control Release. 190:240–253.
   PubMed Web of Science ®Google Scholar
• Selmin F, Musazzi UM, Magri G, Rocco P, Cilurzo F, Minghetti P. 2020. Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies. Drug Discov Today. 25(2):321–329.
   PubMed Web of Science ®Google Scholar
• Shen J, Burgess DJ. 2012. Accelerated in-vitro release testing methods for extended-release parenteral dosage forms. J Pharm Pharmacol. 64(7):986–996.
   PubMed Web of Science ®Google Scholar
• Shen J, Burgess DJ. 2013. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res. 3(5):409–415.
   PubMed Web of Science ®Google Scholar
• Sheshala R, Hong GC, Yee WP, Meka VS, Thakur RRS. 2019. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide. Drug Deliv Transl Res. 9(2):534–542.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Khosla L. 1998. Bioabsorbable polymers for implantable therapeutic systems. Drug Dev Ind Pharm. 24(12):1129–1138.
   PubMed Web of Science ®Google Scholar
• Solorio L, Olear AM, Hamilton JI, Patel RB, Beiswenger AC, Wallace JE, Zhou H, Exner AA. 2012. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Theranostics. 2(11):1064–1077.
   PubMed Web of Science ®Google Scholar
• Stewart SA, Domínguez-Robles J, Donnelly RF, Larrañeta E. 2018. Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers. 10(12):1379.
   PubMed Web of Science ®Google Scholar
• Tang H, Zhao W, Yu J, Li Y, Zhao C. 2018. Recent development of pH-responsive polymers for cancer nanomedicine. Molecules. 24(1):4.
   PubMed Web of Science ®Google Scholar
• Tang Y, Singh J. 2008. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems. Int J Pharm. 357(1–2):119–125.
   PubMedGoogle Scholar
• Thakur RR, McMillan HL, Jones DS. 2014. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release. 176:8–23.
   PubMed Web of Science ®Google Scholar
• Toh MR, Chiu GNC. 2013. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing. Asian J Pharm Sci. 8(2):88–95.
   Google Scholar
• Tsujimoto H, Hara K, Tsukada Y, Huang C, Kawashima Y, Arakaki M, Okayasu H, Mimura H, Miwa N. 2007. Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects. Bioorg Med Chem Lett. 17(17):4771–4777.
   PubMed Web of Science ®Google Scholar
• Uddin R, Saffoon N, Sutradhar KB. 2011. Dissolution and dissolution apparatus: a review. Int J Curr Biomed Pharm Res. 1(4):201–207.
   Google Scholar
• U.S. Pharmacopoeia. 2020. Pharmaceutical dosage forms <1151>. In: U.S. pharmacopoeia. 43th ed.
   Google Scholar
• Verma P, Prajapati SK, Yadav R, Senyschyn D, Shea PR, Trevaskis NL. 2016. Single intravenous dose of novel flurbiprofen-loaded proniosome formulations provides prolonged systemic exposure and anti-inflammatory effect. Mol Pharm. 13(11):3688–3699.
   PubMed Web of Science ®Google Scholar
• Versypt ANF, Pack DW, Braatz RD. 2013. Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres – a review. J Control Release. 165(1):29–37.
   PubMed Web of Science ®Google Scholar
• Vhora I, Khatri N, Misra A. 2021. Applications of polymers in parenteral drug delivery. In: Misra A, Shahiwala A, editors. Applications of polymers in drug delivery. 2nd ed. Netherlands: Elsevier Inc; p. 221–261.
   Google Scholar
• Vineetha K, Koland M. 2017. Investigation of a biodegradable injectable in situ gelling implantable system of rivastigmine tartrate. Asian J Pharm. 11(4):S731–S738.
   Web of Science ®Google Scholar
• Walewijk A, Cooper-White J, Dunstan D. 2008. Adhesion measurements between alginate gel surfaces via texture analysis. Food Hydrocoll. 22(1):91–96.
   Web of Science ®Google Scholar
• Wang B, Friess W. 2018. Lipid-coated mannitol core microparticles for sustained release of protein. Eur J Pharm Biopharm. 128:91–97.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang J, Shao J, Kouwer PHJ, Bronkhorst EM, Jansen JA, Walboomers XF, Yang F. 2020. A tunable and injectable local drug delivery system for personalized periodontal application. J Control Release. 324:134–145.
   PubMed Web of Science ®Google Scholar
• Wang L, Kleiner L, Venkatraman S. 2003. Structure formation in injectable poly(lactide-co-glycolide) depots. J Control Release. 90(3):345–354.
   PubMed Web of Science ®Google Scholar
• Wang L, Lin X, Hong Y, Shen L, Feng Y. 2017. Hydrophobic mixed solvent induced PLGA-based in situ forming systems for smooth long-lasting delivery of radix ophiopogonis polysaccharide in rats. RSC Adv. 7(9):5349–5361.
   Web of Science ®Google Scholar
• Wang L, Wang A, Zhao X, Liu X, Wang D, Sun F, Li Y. 2012. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism. Int J Pharm. 427(2):284–292.
   PubMedGoogle Scholar
• Wang M, Feng Q, Niu X, Tan R, She Z. 2010. A spheres-in-sphere structure for improving protein-loading poly (lactide-co-glycolide) microspheres. Polym Degrad Stab. 95(1):6–13.
   Web of Science ®Google Scholar
• Wang Q, Sun C, Xu B, Tu J, Shen Y. 2018. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. Drug Deliv. 25(1):59–69.
   PubMed Web of Science ®Google Scholar
• Wen H, Jung H, Li X. 2015. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 17(6):1327–1340.
   PubMed Web of Science ®Google Scholar
• Woodard LN, Grunlan MA. 2018. Hydrolytic degradation and erosion of polyester biomaterials. ACS Macro Lett. 7(8):976–982.
   PubMed Web of Science ®Google Scholar
• Wu W, Chen H, Shan F, Zhou J, Sun X, Zhang L, Gong T. 2014. A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery. Mol Pharm. 11(10):3378–3385.
   PubMed Web of Science ®Google Scholar
• Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. 2010. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv. 17(8):561–572.
   PubMed Web of Science ®Google Scholar
• Yadav R, Kanwar IL, Haider T, Pandey V, Gour V, Soni V. 2020. In situ gel drug delivery system for periodontitis: an insight review. Future J Pharm Sci. 6(1):1–13.
   Web of Science ®Google Scholar
• Yaghmur A, Rappolt M, Larsen S. 2013. In situ forming drug delivery systems based on lyotropic liquid crystalline phases: structural characterization and release properties. J Drug Deliv Sci Technol. 23(4):325–332.
   Web of Science ®Google Scholar
• Yan B, Boyer J, Habault D, Branda NR, Zhao Y. 2012. Near infrared light triggered release of biomacromolecules from hydrogels loaded with upconversion nanoparticles. J Am Chem Soc. 134(40):16558–16561.
   PubMed Web of Science ®Google Scholar
• Yang S, Hu M, Liu W, Hou N, Yin K, Shen C, Shang Q. 2021. Fabrication of PLGA in situ forming implants and study on their correlation of in vitro release profiles with in vivo performances. J Biomater Sci Polym Ed. 9:1–15.
   Google Scholar
• Yarnsuphawong P, Thipkunok W, Silaon W, Sritananuwat P, Puapermpoonsiri U. 2015. The study of factors and components in situ forming gel formulation comprising of PLGA. Isan J Pharm Sci. 11(5):135–143.
   Google Scholar
• Zhang K, Shi X, Lin X, Yao C, Shen L, Feng Y. 2014. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats. Drug Deliv. 22(3):375–382.
   PubMed Web of Science ®Google Scholar
• Zhang K, Tang X, Zhang J, Lu W, Lin X, Zhang Y, Tian B, Yang H, He H. 2014. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications. J Control Release. 183:77–86.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Fassihi R. 2020. Release rate determination from in situ gel forming PLGA implant: a novel ‘shape-controlled basket in tube’ method. J Pharm Pharmacol. 72(8):1038–1048.
   PubMed Web of Science ®Google Scholar
• Zhang Y, García-Gabilondo M, Rosell A, Roig A. 2019. MRI/Photoluminescence dual-modal imaging magnetic PLGA nanocapsules for thernaostics. Pharmaceutics. 12(1):16.
   Web of Science ®Google Scholar
• Zheng H, Tai C, Su J, Zou X, Gao F. 2015. Ultra-small mesoporous silica nanoparticles as efficient carriers for pH responsive releases of anti-cancer drugs. Dalton Trans. 44(46):20186–20192.
   PubMed Web of Science ®Google Scholar
• Zhou J, Hirota K, Ackermann R, Walker J, Wang Y, Choi S, Schwendeman A, Schwendeman SP. 2018. Reverse engineering the 1-month lupron depot®. AAPS J. 20(6):105.
   PubMed Web of Science ®Google Scholar